Table III.
Proportion of Clinical Symptoms of HCoV‐HKU1 Infected or Non‐Infected Patients
| No. (%) of HCoV‐HKU1a | No. (%) of non‐HCoV‐HKU1a | |
|---|---|---|
| Rhinorrhea | 36 (72.0) | 1,547 (79.9) |
| Cough | 32 (64.0) | 1,318 (68.1) |
| Stuffy nose | 28 (56.0) | 1,215 (62.8) |
| Fever | 16 (32.0) | 622 (32.1) |
| Sputum | 15 (30.0) | 493 (25.5) |
| Sore throat | 9 (18.0) | 267 (13.8) |
| Chill | 8 (16.0) | 230 (11.9) |
| Postnasal discharge | 7 (14.0) | 332 (17.2) |
| Tonsillar hypertrophy | 5 (10.0) | 114 (5.9) |
| Throat flare | 4 (8.0) | 235 (12.1) |
| Otalgia | 3 (6.0) | 19 (1.0) |
| Pain | 3 (6.0) | 52 (2.7) |
| Hoarseness | 2 (4.0) | 78 (4.0) |
| Eye discharge | 1 (2.0) | 37 (1.9) |
| Otarrhea | 1 (2.0) | 10 (0.5) |
| Wheeze | 0 (0.0) | 37 (1.9) |
| Dyspnea | 0 (0.0) | 38 (2.0) |
a
Clinical symptoms were scored as multiple‐alternative manner.